Prot #TNX-103-06: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF); LEVEL: LEVosimendan to Improve Exercise Lim

Project: Research project

Project Details

StatusActive
Effective start/end date5/7/245/7/27

Funding

  • Medpace Clinical Research LLC (Prot #TNX-103-06 // Prot #TNX-103-06)
  • Tenax Therapeutics, Inc. (Prot #TNX-103-06 // Prot #TNX-103-06)